Background:
Due to aging, along with its associated physiological changes, older adults
are extremely vulnerable to be afflicted with multiple chronic conditions
(multimorbidity). Accordingly, prescribing a large number of drugs to older
adults would be inevitable. Resulted complex drug regimens can lead to
prescribing of Potentially Inappropriate Medications (PIMs) with subsequent
negative health and economic outcomes.
Objectives:
The main objective of this study is to investigate the prevalence and
predictors of PIMs prescribing among Jordanian elderly outpatients, using
the last updated version of the American Geriatrics Society (AGS) Beers
Criteria (2015 version).
Methods:
A Unicenter, cross-sectional study were data was assessed using medical
records of included study subjects conducted over three months period from
beginning of October to the end of December 2016 at King Abdullah University
Hospital, Al Ramtha, Jordan. Our study included patients aged 65 years or
above who visited the outpatient clinics at King Abdullah University
hospital (KAUH) and were prescribed at least one oral medication during the
study period. PIMs were identified for these patients and further classified
according to the 2015 AGS Beers Criteria. We measured the prevalence of PIMs
prescribed among elderly outpatients in Jordan.
Results:
A total of 4622 eligible older adults were evaluated in this study, of whom
62.5% (n=2891) were found to have at least one PIM prescribed during
the three months study period. 69% of identified PIMs were
medications to be used with caution in elderly, 22% were medications
to avoid in many or most older adults, 6.3% were medications to be
avoided or have their dosage adjusted based on kidney function in older
adults, 2.04% medications were to avoid in older adults with specific
diseases/syndromes, and 1.6% were potentially clinically important
non-anti-infective drug-drug interactions to be avoided in older adults.
Female gender and polypharmacy were found to be significant predictors of
PIMs use among elderly.
Conclusions:
Potentially Inappropriate Medication prescribing is common among Jordanian
elderly outpatients. Female gender and polypharmacy are associated with more
PIMs prescribing and so need further attention.
Introduction
Overactive bladder (OAB) is a prevalent syndrome that is associated with multiple urinary tract symptoms and could affect the patient's quality of life and well‐being. Vitamin D is shown to be linked to OAB syndrome, which exacerbated by stress conditions. This study evaluated the relationship between vitamin D status, daily calcium intake and OAB, and the associated psychological symptoms.
Methods
The study included 55 patients with OAB and 129 healthy controls. Psychological symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). Serum vitamin D was measured. Patients with OAB with low vitamin D level received orally vitamin D supplementation. Urinary symptoms, psychological symptoms, and quality of life were evaluated before and after vitamin D supplementation plus dairy products.
Results
Vitamin D deficiency was more prevalent in cases (80%) vs controls (34.9%). Depression (43.7% vs 20.2%) and anxiety (52.8% vs 10.9%) scores (HADS, ≥8) were also more frequent in cases vs controls, respectively. Some 85.5% of the patients’ group had musculoskeletal pain vs 0.0% for the control. Depression was negatively correlated with daily calcium intake and positively with anxiety. Logistic regression analysis revealed that age, vitamin D, and anxiety scores were significant predictors of OAB. Vitamin D supplements with increased calcium intake had significant improvement in urinary symptoms, psychological distress, and quality of life.
Conclusions
Vitamin D supplements and improved calcium intake may improve urinary and psychological symptoms and quality of life among patients with OAB syndrome. Assessment for vitamin D status in patients with OAB may be warranted.
Rationale, aims, and objectives: Clinical pharmacy services are vital in the prevention of adverse drug events (ADEs) in clinical practice, extending beyond the hospital to chronic disease management in outpatient settings. This study sought to evaluate the cost benefit of a clinical pharmacy intervention in resolving treatment-related problems (TRPs) among hospital outpatients with chronic diseases.Methods: From the hospital system perspective, the cost-benefit analysis was based on a randomized clinical trial in the general outpatients of the major hospital in Jordan. Eligible patients were randomly assigned to either an intervention or a control group. TRPs were identified in both study groups, but interventions were delivered only to the intervention group via a home medication management review (HMMR) by a clinical pharmacist. A follow-up in both groups took place 3 months after recruitment. The total economic benefit was the sum of (a) cost savings due to intervention and (b) cost avoidance associated with preventable ADEs. The primary outcome measures were the net benefit and benefit-to-cost ratio with the clinical pharmacist-based HMMR.
Results:In both groups, 158 TRPs were identified, and 79 interventions were provided in the study group. The monthly cost of intervention was JD764 (US $1078), and the total monthly benefit was JD4570 (US $6444), leading to a benefit-to-cost ratio of 5.98 and an annual net benefit of JD45 669 (US $64 393). Sensitivity analyses confirmed the robustness of results.
Conclusion:The RCT-based cost-benefit evaluation provided evidence-based insight into the economic benefit of a clinical pharmacist-provided HMMR for preventing ADEs in the general chronic diseases outpatients. This intervention method against the TRPs among outpatients is cost beneficial and offers substantial cost savings to the health care hospital payer in Jordan.
Objective: To assess the presence of an association between vitamin D deficiency and anaemia in Jordanian infants and toddlers, in whom both vitamin D deficiency and anaemia have previously been proved to be common separately. Design: Cross-sectional prospective study.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.